Loading clinical trials...
Loading clinical trials...
A Randomized, Placebo-Controlled, Double-blind, Fixed-Dose, Multiple Cohort, Multiple Crossover, Dose-Finding Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2
Conditions
Interventions
BTD-001
Placebo
Locations
23
United States
Sleep Disorders Center of Alabama
Birmingham, Alabama, United States
Stanford Medicine Sleep Center
Palo Alto, California, United States
Pacific Research Network
San Diego, California, United States
Empire Clinical Research
Upland, California, United States
REM Sleep Medicine, Colorado Sleep Institute
Boulder, Colorado, United States
PAB Clinical Research
Brandon, Florida, United States
Start Date
September 1, 2015
Primary Completion Date
February 1, 2018
Completion Date
February 1, 2018
Last Updated
January 16, 2019
NCT06457945
NCT04330963
NCT05371483
NCT06525077
NCT06251063
NCT04026958
Lead Sponsor
Balance Therapeutics
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions